Last 7 days
-12.3%
Last 30 days
-12.4%
Last 90 days
-41.3%
Trailing 12 Months
8.4%
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
2023-09-14 | NELSON MARILYN C | acquired | 1,880 | 0.94 | 2,000 | - |
2023-09-08 | Herbert Timothy P. | sold | - | - | -47,992 | ceo and president |
2023-09-08 | Herbert Timothy P. | gifted | - | - | -47,992 | ceo and president |
2023-08-28 | Jandrich Steven | acquired | 2,350 | 0.94 | 2,500 | vp, human resources |
2023-08-24 | Herbert Timothy P. | gifted | - | - | -3,224 | ceo and president |
2023-08-23 | Herbert Timothy P. | acquired | 67,230 | 70.5459 | 953 | ceo and president |
2023-08-21 | NELSON MARILYN C | acquired | 1,880 | 0.94 | 2,000 | - |
2023-08-10 | NELSON MARILYN C | acquired | 1,880 | 0.94 | 2,000 | - |
2023-08-07 | NELSON MARILYN C | acquired | 1,880 | 0.94 | 2,000 | - |
2023-08-04 | NELSON MARILYN C | acquired | 1,880 | 0.94 | 2,000 | - |
Datesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
2023-09-21 | Baystate Wealth Management LLC | unchanged | - | 4,067 | 14,578 | -% |
2023-09-20 | BARCLAYS PLC | added | 33.78 | 5,976,000 | 12,966,000 | 0.01% |
2023-09-12 | Farther Finance Advisors, LLC | new | - | 649 | 649 | -% |
2023-08-29 | EFG Asset Management (Americas) Corp. | new | - | 830,104 | 830,104 | 0.19% |
2023-08-23 | Stonebridge Capital Advisors LLC | unchanged | - | 14,944 | 53,566 | 0.01% |
2023-08-22 | VIRGINIA RETIREMENT SYSTEMS ET AL | added | 42.42 | 753,377 | 1,525,810 | 0.01% |
2023-08-21 | CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | reduced | -2.06 | 3,022,040 | 11,453,900 | 0.02% |
2023-08-21 | BOKF, NA | reduced | -2.54 | 803,906 | 3,089,600 | 0.06% |
2023-08-21 | OSAIC HOLDINGS, INC. | added | 44.59 | 3,131,220 | 6,246,700 | 0.01% |
2023-08-21 | TEACHERS RETIREMENT SYSTEM OF THE STATE OF KENTUCKY | unchanged | - | 445,000 | 1,595,000 | 0.01% |
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Feb 09, 2023 | fmr llc | - | 0 | SC 13G/A | |
Feb 09, 2023 | vanguard group inc | 10.31% | 2,978,391 | SC 13G/A | |
Jan 31, 2023 | blackrock inc. | 7.4% | 2,135,708 | SC 13G/A | |
Nov 10, 2022 | vanguard group inc | 10.04% | 2,899,902 | SC 13G/A | |
Feb 03, 2022 | blackrock inc. | 6.7% | 1,846,227 | SC 13G/A | |
Jan 10, 2022 | fmr llc | - | 0 | SC 13G/A | |
Feb 12, 2021 | orbimed advisors llc | 0.00% | 0 | SC 13G/A | |
Feb 10, 2021 | vanguard group inc | 8.92% | 2,401,971 | SC 13G | |
Feb 08, 2021 | fmr llc | - | 0 | SC 13G/A | |
Feb 02, 2021 | blackrock inc. | 7.4% | 1,993,714 | SC 13G |
Date Filed | Form Type | Document | |
---|---|---|---|
Sep 18, 2023 | 4 | Insider Trading | |
Sep 13, 2023 | 4 | Insider Trading | |
Aug 30, 2023 | 4 | Insider Trading | |
Aug 28, 2023 | 4 | Insider Trading | |
Aug 28, 2023 | 4 | Insider Trading | |
Aug 22, 2023 | 4 | Insider Trading | |
Aug 11, 2023 | 4 | Insider Trading | |
Aug 09, 2023 | 4 | Insider Trading | |
Aug 08, 2023 | 4 | Insider Trading | |
Aug 02, 2023 | 3 | Insider Trading |
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
SYK | 108.3B | 19.5B | 3.38% | 36.58% | 39.99 | 5.57 | 10.36% | 30.30% |
ISRG | 103.0B | 6.7B | -0.75% | 50.83% | 72.29 | 15.46 | 11.75% | -0.66% |
BSX | 77.8B | 13.4B | 6.45% | 36.39% | 85.31 | 5.81 | 8.69% | 3.17% |
BDX | 71.3B | 19.0B | -4.29% | 12.66% | 44.09 | 3.79 | 0.46% | -5.24% |
EW | 42.2B | 5.7B | -8.22% | -17.24% | 30.39 | 7.46 | 5.64% | -4.53% |
MID-CAP | ||||||||
PEN | 9.5B | 937.8M | -2.12% | 37.22% | 325.65 | 10.11 | 16.30% | 250.21% |
INSP | 5.4B | 526.1M | -12.44% | 8.39% | -132.09 | 10.31 | 74.86% | 6.49% |
GMED | 5.1B | 1.1B | -6.10% | -12.07% | 24.23 | 4.65 | 12.63% | 50.85% |
IRTC | 2.6B | 452.1M | -21.20% | -33.94% | -26.32 | 5.78 | 24.99% | 24.09% |
OMCL | 2.3B | 1.2B | -12.37% | -42.27% | -97.15 | 1.82 | -1.77% | -138.27% |
SMALL-CAP | ||||||||
SDGR | 2.1B | 193.8M | -23.50% | 16.21% | 31.34 | 10.73 | 18.78% | 144.88% |
AVNS | 947.4M | 780.7M | -7.75% | -9.65% | -26.32 | 1.21 | 4.68% | -510.17% |
ICAD | 47.7M | 24.5M | -18.18% | -19.57% | -3.81 | 1.95 | -24.11% | 3.57% |
HTGM | 1.3M | 6.2M | -81.65% | 3.23% | -0.06 | 0.21 | -28.21% | -7.22% |
33.0%
13.1%
96.5%
73.5%
29.6%
Y-axis is the maximum loss one would have experienced if Inspire Medical Systems was unfortunately bought at previous high price.
Income Statement (Last 12 Months) | ||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 | 2018Q2 |
Revenue | 12.8% | 526,077,000 | 466,371,000 | 407,856,000 | 348,354,000 | 300,851,000 | 262,424,000 | 233,394,000 | 201,005,000 | 175,162,000 | 134,386,000 | 115,381,000 | 96,278,000 | 81,298,000 | 87,147,000 | 82,050,000 | 71,703,000 | 63,895,000 | 56,801,000 | 50,593,000 | 43,991,000 | 38,208,000 |
Gross Profit | 12.7% | 439,999,000 | 390,372,000 | 341,741,000 | 293,235,000 | 256,894,000 | 225,122,000 | 200,115,000 | 171,721,000 | 149,291,000 | 114,079,000 | 97,758,000 | 81,577,000 | 68,352,000 | 73,061,000 | 68,407,000 | 59,106,000 | 52,287,000 | 46,185,000 | 40,537,000 | 35,247,000 | 30,366,000 |
Operating Expenses | 11.8% | 493,625,000 | 441,406,000 | 389,333,000 | 342,313,000 | 298,574,000 | 265,339,000 | 239,965,000 | 216,812,000 | 194,478,000 | 169,536,000 | 153,966,000 | 140,016,000 | 125,550,000 | 115,621,000 | 103,304,000 | 89,607,000 | 78,786,000 | 70,145,000 | 60,915,000 | 54,574,000 | 48,693,000 |
S&GA Expenses | 10.0% | 395,044,000 | 359,112,000 | 320,688,000 | 284,622,000 | 252,262,000 | 224,273,000 | 202,615,000 | 182,471,000 | 162,444,000 | 140,728,000 | 127,874,000 | 117,442,000 | 106,660,000 | 99,947,000 | 90,465,000 | 78,383,000 | 69,414,000 | 61,884,000 | 53,527,000 | 50,208,000 | 44,058,000 |
R&D Expenses | 19.8% | 98,581,000 | 82,294,000 | 68,645,000 | 57,691,000 | 46,312,000 | 41,066,000 | 37,350,000 | 34,341,000 | 32,034,000 | 28,808,000 | 26,092,000 | 22,574,000 | 18,890,000 | 15,674,000 | 12,839,000 | 11,224,000 | 9,372,000 | 8,261,000 | 7,388,000 | 6,918,000 | 6,323,000 |
EBITDA | 100.0% | - | -39,640,000 | -40,733,000 | -46,066,000 | -40,105,000 | -38,939,000 | -38,642,000 | -43,932,000 | -43,990,000 | -54,121,000 | -54,171,000 | -55,758,000 | -53,811,000 | -38,475,000 | -30,584,000 | - | - | - | - | - | - |
EBITDA Margin | 100.0% | - | -0.08 | -0.10 | -0.13 | -0.13 | -0.15 | -0.17 | -0.22 | -0.25 | -0.40 | -0.47 | -0.58 | -0.66 | -0.44 | -0.37 | - | - | - | - | - | - |
Interest Expenses | -43.0% | 656,000 | 1,150,000 | 1,677,000 | 2,215,000 | 2,096,000 | 2,132,000 | 2,128,000 | 2,123,000 | 2,119,000 | 2,115,000 | 2,117,000 | 2,114,000 | 2,110,000 | 2,107,000 | 2,119,000 | 2,278,000 | 2,429,000 | 2,456,000 | 3,304,000 | 3,144,000 | 2,892,000 |
Earnings Before Taxes | 6.1% | -40,272,000 | -42,882,000 | -44,268,000 | -49,914,000 | -43,657,000 | -42,371,000 | -41,970,000 | -47,055,000 | -47,009,000 | -57,036,000 | -57,088,000 | -58,672,000 | -56,621,000 | -41,182,000 | -33,203,000 | -28,941,000 | -25,387,000 | -23,593,000 | -21,828,000 | -21,301,000 | -20,631,000 |
EBT Margin | 100.0% | - | -0.09 | -0.11 | -0.14 | -0.15 | -0.16 | -0.18 | -0.23 | -0.27 | -0.42 | -0.49 | -0.61 | -0.70 | -0.47 | -0.40 | - | - | - | - | - | - |
Net Income | 5.8% | -41,073,000 | -43,611,000 | -44,881,000 | -50,422,000 | -43,922,000 | -42,520,000 | -42,042,000 | -47,135,000 | -47,173,000 | -57,174,000 | -57,203,000 | -58,799,000 | -56,661,000 | -41,222,000 | -33,243,000 | -28,941,000 | -25,387,000 | -23,593,000 | -21,828,000 | -21,302,000 | -20,631,000 |
Net Income Margin | 100.0% | - | -0.09 | -0.11 | -0.14 | -0.15 | -0.16 | -0.18 | -0.23 | -0.27 | -0.43 | -0.50 | -0.61 | -0.70 | -0.47 | -0.41 | - | - | - | - | - | - |
Free Cashflow | -100.0% | - | 11,339,000 | 2,473,000 | -13,645,000 | -22,624,000 | -27,028,000 | -24,787,000 | -29,702,000 | -38,337,000 | -52,192,000 | -55,500,000 | -57,304,000 | -51,188,000 | -39,398,000 | -35,585,000 | - | - | - | - | - | - |
Balance Sheet | (In Millions) | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 | 2018Q2 |
Assets | 8.1% | 618 | 572 | 565 | 528 | 292 | 290 | 295 | 279 | 272 | 273 | 281 | 272 | 271 | 166 | 181 | 183 | 186 | 190 | 200 | 131 | 134 |
Current Assets | 5.0% | 560 | 534 | 530 | 496 | 263 | 262 | 269 | 255 | 249 | 261 | 270 | 267 | 267 | 155 | 171 | 170 | 177 | 189 | 199 | 130 | 133 |
Cash Equivalents | 5.6% | 467 | 442 | 442 | 418 | 187 | 203 | 214 | 210 | 177 | 182 | 191 | 179 | 211 | 76.00 | 23.00 | 48.00 | 51.00 | 102 | 97.00 | 26.00 | 122 |
Inventory | 33.1% | 21.00 | 16.00 | 12.00 | 15.00 | 22.00 | 22.00 | 17.00 | 16.00 | 13.00 | 11.00 | 8.00 | 9.00 | 10.00 | 7.00 | 6.00 | 5.00 | 4.00 | 3.00 | 3.00 | 3.00 | 4.00 |
Net PPE | 20.5% | 25.00 | 21.00 | 17.00 | 14.00 | 11.00 | 9.00 | 8.00 | 8.00 | 7.00 | 7.00 | 5.00 | 4.00 | 3.00 | 3.00 | 3.00 | 3.00 | 2.00 | 1.00 | 1.00 | 1.00 | 1.00 |
Liabilities | 32.3% | 89.00 | 67.00 | 69.00 | 57.00 | 65.00 | 65.00 | 66.00 | 59.00 | 52.00 | 50.00 | 51.00 | 43.00 | 38.00 | 38.00 | 41.00 | 37.00 | 33.00 | 32.00 | 36.00 | - | - |
Current Liabilities | 11.4% | 67.00 | 60.00 | 61.00 | 49.00 | 47.00 | 43.00 | 41.00 | 34.00 | 24.00 | 19.00 | 21.00 | 18.00 | 13.00 | 14.00 | 17.00 | 13.00 | 9.00 | 8.00 | 11.00 | 8.00 | 9.00 |
Shareholder's Equity | 4.9% | 529 | 505 | 496 | 470 | 227 | 225 | 229 | 220 | 220 | 223 | 230 | 229 | 234 | 127 | 140 | 146 | 152 | 157 | 164 | 98.00 | 103 |
Retained Earnings | -3.5% | -351 | -339 | -324 | -327 | -310 | -296 | -279 | -277 | -266 | -253 | -237 | -229 | -219 | -196 | -180 | -171 | -162 | -155 | -146 | -142 | -137 |
Additional Paid-In Capital | 4.3% | 881 | 844 | 820 | 798 | 538 | 521 | 508 | 497 | 487 | 477 | 467 | 459 | 453 | 323 | 320 | 317 | 315 | 313 | 311 | 240 | 240 |
Accumulated Depreciation | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
Shares Outstanding | 0.6% | 29.00 | 29.00 | 29.00 | 29.00 | 28.00 | 28.00 | 27.00 | 27.00 | 27.00 | 27.00 | 27.00 | 27.00 | 26.00 | 24.00 | 24.00 | 24.00 | 24.00 | 23.00 | 15.00 | 12.00 | 14.00 |
Cashflow (Last 12 Months) | (In Thousands) | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 | 2018Q2 |
Cashflow From Operations | 48.1% | 34,019 | 22,973 | 11,569 | -6,966 | -18,306 | -22,466 | -20,119 | -24,963 | -33,534 | -48,671 | -53,045 | -55,011 | -49,046 | -36,679 | -32,846 | -29,359 | -29,968 | -23,218 | -18,694 | -19,382 | -18,956 |
Share Based Compensation | 14.7% | 69,382 | 60,474 | 51,970 | 43,999 | 36,220 | 29,902 | 26,178 | 23,002 | 19,503 | 16,065 | 12,817 | 10,856 | 9,069 | 7,555 | 6,197 | 4,827 | 3,675 | 2,555 | 1,219 | 750 | 459 |
Cashflow From Investing | 74.5% | -5,570 | -21,884 | -19,596 | -17,179 | 16,732 | 28,995 | 29,139 | 41,068 | -15,010 | 18,065 | 86,627 | 55,239 | 80,667 | 7,726 | -43,559 | -19,945 | -111,478 | -67,858 | -83,389 | -89,459 | -2,351 |
Cashflow From Financing | 6.0% | 251,979 | 237,664 | 235,077 | 231,864 | 11,582 | 14,442 | 14,948 | 15,393 | 13,862 | 136,828 | 134,065 | 130,441 | 128,321 | 3,117 | 1,964 | 70,977 | 70,831 | 181,832 | 190,383 | 120,613 | 120,653 |
Consolidated Statements of Operations and Comprehensive Loss (unaudited) - USD ($) $ in Thousands | 3 Months Ended | 6 Months Ended | ||
---|---|---|---|---|
Jun. 30, 2023 | Jun. 30, 2022 | Jun. 30, 2023 | Jun. 30, 2022 | |
Income Statement [Abstract] | ||||
Revenue | $ 151,092 | $ 91,386 | $ 278,989 | $ 160,768 |
Cost of goods sold | 24,252 | 14,173 | 44,140 | 24,177 |
Gross profit | 126,840 | 77,213 | 234,849 | 136,591 |
Operating expenses: | ||||
Research and development | 30,821 | 14,534 | 56,340 | 26,404 |
Selling, general and administrative | 112,618 | 76,686 | 214,606 | 140,250 |
Total operating expenses | 143,439 | 91,220 | 270,946 | 166,654 |
Operating loss | (16,599) | (14,007) | (36,097) | (30,063) |
Other expense (income): | ||||
Interest and dividend income | (4,922) | (297) | (9,195) | (331) |
Interest expense | 0 | 494 | 0 | 1,021 |
Other expense, net | 61 | 144 | 44 | 189 |
Total other (income) expense | (4,861) | 341 | (9,151) | 879 |
Loss before income taxes | (11,738) | (14,348) | (26,946) | (30,942) |
Income taxes | 214 | 142 | 430 | 242 |
Net loss | (11,952) | (14,490) | (27,376) | (31,184) |
Other comprehensive loss: | ||||
Foreign currency translation gain | 72 | 42 | 177 | 42 |
Unrealized (loss) gain on investments | (1) | (45) | 12 | (188) |
Total comprehensive loss | $ (11,881) | $ (14,493) | $ (27,187) | $ (31,330) |
Net loss per share, basic (in dollars per share) | $ (0.41) | $ (0.53) | $ (0.94) | $ (1.13) |
Net loss per share, diluted (in dollars per share) | $ (0.41) | $ (0.53) | $ (0.94) | $ (1.13) |
Weighted average common shares used to compute net loss per share, basic (in shares) | 29,229,922 | 27,594,874 | 29,160,323 | 27,556,286 |
Weighted average common shares used to compute net loss per share, diluted (in shares) | 29,229,922 | 27,594,874 | 29,160,323 | 27,556,286 |
Consolidated Balance Sheets - USD ($) $ in Thousands | Jun. 30, 2023 | Dec. 31, 2022 |
---|---|---|
Current assets: | ||
Cash and cash equivalents | $ 467,051 | $ 441,592 |
Investments, short-term | 0 | 9,821 |
Accounts receivable, net of allowance for credit losses of $917 and $36, respectively | 63,500 | 61,228 |
Inventories, net | 20,840 | 11,886 |
Prepaid expenses and other current assets | 8,685 | 5,505 |
Total current assets | 560,076 | 530,032 |
Property and equipment, net | 25,217 | 17,249 |
Operating lease right-of-use assets | 21,368 | 6,880 |
Other non-current assets | 11,585 | 10,715 |
Total assets | 618,246 | 564,876 |
Current liabilities: | ||
Accounts payable | 39,961 | 26,847 |
Accrued expenses | 26,726 | 34,339 |
Total current liabilities | 66,687 | 61,186 |
Operating lease liabilities, non-current portion | 22,054 | 7,536 |
Other non-current liabilities | 146 | 146 |
Total liabilities | 88,887 | 68,868 |
Stockholders' equity: | ||
Preferred Stock, $0.001 par value, 10,000,000 shares authorized; no shares issued and outstanding | 0 | 0 |
Common Stock, $0.001 par value per share; 200,000,000 shares authorized; 29,326,179 and 29,008,368 issued and outstanding at June 30, 2023 and December 31, 2022, respectively | 29 | 29 |
Additional paid-in capital | 880,873 | 820,335 |
Accumulated other comprehensive income (loss) | 103 | (86) |
Accumulated deficit | (351,646) | (324,270) |
Total stockholders' equity | 529,359 | 496,008 |
Total liabilities and stockholders' equity | $ 618,246 | $ 564,876 |